Hormonal regulatory influence in tear film;Influence des hormones sur le film lacrymal

Journal Francais d'Ophtalmologie

Volumn 27, Issue 8, 2004, Pages 933-941

  Oprea, L ^a   Tiberghien, A ^a   Creuzot Garcher, C ^b   Baudouin, C ^a,c,d  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Androgens; Estrogens; Lacrimal glands; Progesterone; Prolactin; Sex hormones; Tear film

Indexed keywords

ANDROGEN; ESTROGEN; IMMUNOGLOBULIN A; PROGESTERONE; PROLACTIN;

ADULT; AGED; AGING; ANDROGEN BLOOD LEVEL; ANIMAL MODEL; CASTRATION; ESTROGEN BLOOD LEVEL; EYE; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSECTOMY; IMMUNE SYSTEM; LACRIMAL APPARATUS; LACRIMAL GLAND; LACRIMAL GLAND DISEASE; MALE; MEIBOMIAN GLAND; MENOPAUSE; MOUSE; NONHUMAN; OVARIECTOMY; REVIEW; SJOEGREN SYNDROME; TEAR FILM;

EID: 6444227362     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(04)96241-9     Document Type: Review

References (51)

1. Lozato PA, Pisella PJ, Baudouin C. La couche lipidique du film lacrymal: physiologie et pathologie. J Fr Ophtalmol, 2001;24:643-58.
2. Garcher C, Bron A, Baudouin C, Bildstein L, Bara J. CA 19-9 ELISA test: a new method for studying mucus changes in tears. Br J Ophthalmol, 1998;82:88-90.
3. Hoang-Xuan T, Baudouin C, Creuzot-Garcher C. Inflammatory Diseases of the conjunctiva. Creuzot-Garcher C. Focus 2: the tear film. New York: Thieme; 2001, p. 8-10.
4. Hoang-Xuan T, Baudouin C, Creuzot-Garcher C. Inflammatory Diseases of the conjunctiva. In: Creuzot-Garcher C. Focus 3: mucus. New York: Thieme; 2001, p. 12-5.
5. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scandinav, 2000;78:146-53.
6. Sullivan DA, Sullivan BD, Ullman MD, Rocha EM, Krenzer KL, Cermak JM et al. Androgen influence on the Meibomian gland. Invest Ophthalmol Vis Sci, 2000;41:3732-42.
7. Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in Meibomian glands. Ophthalmology, 2000;107:180-4.
8. Sullivan DA, Edwards JA, Wickham LA, Pena JDO, Gao J et al. Identification and endocrine control of sex steroid binding sites in the lacrimal gland. Curr Eye Res, 1996;15:279-91.
9. Rocha FJ, Wickham LA, Pena JDO, Gao J, Ono M, Lambert RW et al. Influence of gender and the endocrine environnement on the distribution of androgen receptors in the lacrimal gland. J Steroid Bioch Mol Biol, 1993;46:737-49.
10. Rocha EM, Wickham LA, Da Silveira LA, Krenzer KL, Fu-Shin Yu, Toda I et al. Identification of androgen receptor protein and 5α-reductase m-RNA in human ocular tissues. Br J Ophthalmol, 2000;84:77-84.
11. Cavallero C. Relative effectiveness of various steroids in an androgen assay using the exorbital lacrimal gland of the castrated rat. Acta Endo, 1967;55:119-30.
12. Luo F, Zhang H, Sun X. The change of tear secretion and tear film stability in castrated male rabbits. Chung Hua Yen Ko Tsa Chin, 2001;37:458-61.
13. Azzarolo AM, Bjerrum K, Maves CA, Becker L, Wood RL, Mircheff AK et al. Hypophysectomy-induced regression of female rat lacrimal glands: partial restoration and maintenance by dihydrotestostérone and prolactin. Invest Ophthalmol Vis Sci, 1995;36:216-26.
14. Azzarolo AM, Mircheff AK, Kaswan R, Stanczyk FZ, Gentschein E, Becker L et al. Androgen support of lacrimal gland function. Endocrine, 1997;6:39-45.
15. Azzarolo AM, Olsen E, Huang ZM, Yasharel R, Mircheff AK, Wood RL et al. Rapid onset of cell death in lacrimal glands after ovariectomy. Invest Ophthalmol Vis Sci, 1996;37;S856.
16. Azzarolo AM, Mircheff AK, Kaswan R, Warren DW. Hypothesis for an indirect role of estrogens in maintaining lacrimal gland function. Invest Ophthalmol Vis Sci, 1993;34:S1466.
17. Huang ZM, Azzarolo AM, Mircheff AK, Esrail R, Grayson G, Heller K et al. Does estrogen directly affect lacrimal gland function? Invest Ophthalmol Vis Sci, 1995;36:S651.
18. Wood RL, Zhang J, Huang ZM, Gierow JP, Schlechter JE, Mircheff AK et al. Prolactin and prolactin receptors in the lacrimal gland. Exp Eye Res, 1999;69:213-26.
19. Azzarolo AM, Mazaheri AH, Mircheff AK, Warren DW. Sex-dependent parameters related to electrolyte, water and glycoprotein secretion in rabbit lacrimal glands. Curr Eye Res, 1993;12:795-802.
20. Cornell-Bell AH, Sullivan DA, Allansmith MR. Gender-related differences in the morphology of the lacrimal gland. Invest Ophthalmol Vis Sci, 1985;26:1170-5.
21. Sullivan DA, Hann LE, Yee L, Allansmith MR. Age and gender-related influence on the lacrimal gland and tears. Acta Ophthalmol Scandinav, 1990;68:188-94.
22. Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, Da Silveira LA, Toda I. Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol, 1998;438:11-42.
23. Sullivan DA, Block L, Pena JDO. Influence of androgens and pituitary hormones on the structural profile and secretory activity of the lacrimal gland. Acta Ophthalmol Scandinav, 1996;74: 421-35.
24. Mircheff AK, Warren DW, Wood RL. Hormonal support of lacrimal function, primary lacrimal deficiency, autoimmunity, and peripheral tolerance in the lacrimal gland. Ocul Immunol Inflam, 1996;4:145-72.
25. Henderson JW, Prough WA. Influence of age and sex on flow of tears. Arch Ophthalmol, 1950;43:224-31.
26. Sullivan DA, Allansmith MR. Hormonal modulation of tear volume in the rat. Exp Eye Res, 1986;42:131-9.
27. Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yamagami H, Liu M et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci, 2002;966:211-22.
28. Sullivan DA, Wickham LA, Rocha EM, Krenzer KL, Sullivan BD, Steagall R et al. Androgens and dry eye in Sjögren's syndrome. Ann N Y Acad Sci, 1999;876:312-24.
29. Sullivan DA, Rocha EM, Ullman MD, Krenzer KL, Gao J, Toda I et al. Androgen regulation of the Meibomian gland. Adv Exp Med Biol, 1998;438:327-31.
30. Krenzer KL, Dana MR, Ullman MD, Cermak JM, Tolls DB, Evans J et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endo Metabol, 2000;85:4874-82.
31. Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjonctivitis sicca with topical androgen. Maturitas, 2001;37:209-12.
32. Hann LE, Allansmith MR, Sullivan DA. Impact of aging and gender on the Ig-containing cell profile of the lacrimal gland. Acta Ophthalmol Scandinav, 1988;66:87-92.
33. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen modulation of IgA levels in tears of rats. J Immunol, 1985;134:2978-82.
34. Sullivan DA, Bloch KJ, Allansmith MR. Hormonal influence on the secretory immune system of the eye: androgen control of secretory component production by the rat exorbital gland. Immunol, 1984;52:239-45.
35. Sullivan DA, Allansmith MR. Hormonal influence on the secretory immune system of the eye: endocrine interactions in the control of IgA and secretory component levels in tears of rats. Immunol, 1987;60:337-43.
36. Baudouin C. The pathology of dry eye. Surv Ophthalmol, 2001;45:S211-20.
37. Wenderlein M, Mattes S. The "dry eye" phenomenon and ovarian function. Study of 700 women pre-and postmenopausal. Zentralbl Gynakol, 1996;118:643-9.
38. Okon A, Jurowski P, Gos R. The influence of the hormonal replacement therapy on the amount and stability of the tear film among peri-and postmenopausal women. Klin Oczna, 2001;103:177-81.
39. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA, 2001;7;286:2114-9.
40. Mathers WD, Stovall D, Lane JA, Zimmerman MB, Johnson S. Menopause and tear function: the influence of prolactin and sex hormones on human tear production. Cornea, 1998;17:353-8.
41. Frankel SH, Ellis PP. Effect of oral contraceptives on tear production. Annals Ophthalmol, 1978;10:1585-8.
42. Ehrich W, Ziegler P. L'épreuve du Schirmer I, les contraceptifs oraux et la grossesse. Contactologia, 1981;3:128-130.
43. Vessey MP, Hannaford P, Mant J, Painter R, Frith P, Chappel D. Oral contraception and eye disease: finding in two large cohort studies. Br J Ophthalmol, 1998;82:538-42.
44. Tomlinson A, Pearce EI, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthalmol Physiol Opto, 2001;21:9-16.
45. Feldman F, Bain J, Matuk. Daily assessment of ocular and hormonal variables throughout the menstrual cycle. Arch Ophthalmol, 1978;96:1835-8.
46. De Vries Reilingh, Reiners H, Van Bijsterveld OP. Contact lens tolerance and oral contraceptives. Ann Ophthalmol, 1978;10:947-52.
47. Yolton DP, Yolton RL, Lopez R, Bogner B, Stevens R, Rao D. The effects of gender and birth control pill use on spontaneous blink rates. J Am Opto Ass, 1994;65:763-70.
48. Sato EH, Sullivan DA. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome. Invest Ophthalmol Vis Sci, 1994;35:2632-42.
49. Vendramini ACLM, Soo C, Sullivan DA. Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's syndrome. Invest Ophthalmol Vis Sci, 1991;32:3002-6.
50. Sullivan DA, Edwards JA. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome. J Steroid Bio Mol, 1997;60:237-45.
51. Pisella PJ, Creuzot-Garcher C, Baudouin C. Current Aspects of Gougerot-Sjogren Syndrome. J Fr Ophtalmol, 1999;22:889-92.